|
US5800815A
(en)
|
1903-05-05 |
1998-09-01 |
Cytel Corporation |
Antibodies to P-selectin and their uses
|
|
US4450103A
(en)
|
1982-03-01 |
1984-05-22 |
Cetus Corporation |
Process for recovering human IFN-β from a transformed microorganism
|
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
|
US4737462A
(en)
|
1982-10-19 |
1988-04-12 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4959314A
(en)
|
1984-11-09 |
1990-09-25 |
Cetus Corporation |
Cysteine-depleted muteins of biologically active proteins
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
AU631802B2
(en)
|
1988-06-14 |
1992-12-10 |
Cetus Oncology Corporation |
Coupling agents and sterically hindered disulfide linked conjugates prepared therefrom
|
|
CA1341373C
(en)
|
1988-06-24 |
2002-07-02 |
Roberta C. Cheng |
Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
|
|
US5753627A
(en)
|
1988-12-05 |
1998-05-19 |
Novartis Ag |
Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5705363A
(en)
|
1989-03-02 |
1998-01-06 |
The Women's Research Institute |
Recombinant production of human interferon τ polypeptides and nucleic acids
|
|
DK0436005T3
(da)
|
1989-07-20 |
1995-07-03 |
Sandoz Ltd |
Mærkede polypeptidderivater
|
|
US5730978A
(en)
|
1989-09-01 |
1998-03-24 |
Fred Hutchinson Cancer Research Center |
Inhibition of lymphocyte adherence with α4β1-specific antibodies
|
|
US6033665A
(en)
|
1989-09-27 |
2000-03-07 |
Elan Pharmaceuticals, Inc. |
Compositions and methods for modulating leukocyte adhesion to brain endothelial cells
|
|
US5292658A
(en)
|
1989-12-29 |
1994-03-08 |
University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center |
Cloning and expressions of Renilla luciferase
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
IL99552A0
(en)
|
1990-09-28 |
1992-08-18 |
Ixsys Inc |
Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
|
|
FI933508L
(fi)
|
1991-12-10 |
1993-08-31 |
Dow Chemical Co |
Bicyklopolyazamakrocyklokarboxylsyrakomplex, konjugat daerav, foerfarande foer deras framstaellning och anvaendning som radiofarmaceutiska medel
|
|
DK0626861T4
(da)
|
1992-01-13 |
2004-08-16 |
Biogen Inc |
Behandling af astma.
|
|
JPH07506566A
(ja)
|
1992-02-12 |
1995-07-20 |
バイオゲン インコーポレイテッド |
炎症性胃腸病の処置
|
|
CA2153228A1
(en)
|
1993-01-08 |
1994-07-21 |
Shiu-Lan Ng Chiang |
Peptide inhibitors of cell adhesion
|
|
DE69419721T2
(de)
|
1993-01-12 |
2000-04-27 |
Biogen, Inc. |
Rekombinante anti-vla4 antikörpermoleküle
|
|
US5928904A
(en)
|
1993-09-07 |
1999-07-27 |
Smithkline Beecham Corporation |
DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
|
|
US5914110A
(en)
|
1993-09-07 |
1999-06-22 |
Smithkline Beecham Corporation |
Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
|
|
WO1995015973A1
(en)
|
1993-12-06 |
1995-06-15 |
Cytel Corporation |
Cs-1 peptidomimetics, compositions and methods of using the same
|
|
US5821231A
(en)
|
1993-12-06 |
1998-10-13 |
Cytel Corporation |
CS-1 peptidomimetics, compositions and methods of using same
|
|
US5936065A
(en)
|
1993-12-06 |
1999-08-10 |
Cytel Corporation |
CS-1 peptidomimetics, compositions and methods of using the same
|
|
US5840299A
(en)
|
1994-01-25 |
1998-11-24 |
Athena Neurosciences, Inc. |
Humanized antibodies against leukocyte adhesion molecule VLA-4
|
|
HU220799B1
(hu)
|
1994-01-25 |
2002-05-28 |
Elan Pharmaceuticals, Inc. |
Humanizált antitestek VLA-4 leukocita adhéziós molekula ellen
|
|
US8715645B2
(en)
|
1994-05-27 |
2014-05-06 |
The Regents Of The University Of Colorado |
Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same
|
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
AU2958195A
(en)
|
1994-06-29 |
1996-01-25 |
Texas Biotechnology Corporation |
Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin
|
|
US5811391A
(en)
|
1994-08-25 |
1998-09-22 |
Cytel Corporation |
Cyclic CS-1 peptidomimetics, compositions and methods of using same
|
|
US5874540A
(en)
|
1994-10-05 |
1999-02-23 |
Immunomedics, Inc. |
CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
|
|
US5674842A
(en)
|
1994-10-26 |
1997-10-07 |
Health Research, Incorporated |
Growth inhibitory peptide
|
|
US5670356A
(en)
|
1994-12-12 |
1997-09-23 |
Promega Corporation |
Modified luciferase
|
|
US6306840B1
(en)
|
1995-01-23 |
2001-10-23 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
WO1996040781A1
(en)
|
1995-06-07 |
1996-12-19 |
Tanabe Seiyaku Co., Ltd. |
CYCLIC PEPTIDE INHIBITORS OF β1 AND β2 INTEGRIN-MEDIATED ADHESION
|
|
US5977322A
(en)
*
|
1995-06-14 |
1999-11-02 |
The Regents Of The University Of California |
High affinity human antibodies to tumor antigens
|
|
US6034057A
(en)
|
1995-07-06 |
2000-03-07 |
Zeneca Limited |
Peptide inhibitors of fibronectine
|
|
US6248713B1
(en)
|
1995-07-11 |
2001-06-19 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
GB9613112D0
(en)
|
1996-06-21 |
1996-08-28 |
Zeneca Ltd |
Chemical compounds
|
|
NZ333904A
(en)
|
1996-07-25 |
2000-06-23 |
Biogen Inc |
VLA-4 and IIb/IIIa cell adhesion inhibitors
|
|
US6686350B1
(en)
|
1996-07-25 |
2004-02-03 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
DE19647380A1
(de)
|
1996-11-15 |
1998-05-20 |
Hoechst Ag |
5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
|
|
DE19647381A1
(de)
|
1996-11-15 |
1998-05-20 |
Hoechst Ag |
Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
|
|
DE19647382A1
(de)
|
1996-11-15 |
1998-05-20 |
Hoechst Ag |
Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
|
|
WO1998042656A1
(en)
|
1997-03-21 |
1998-10-01 |
Cytel Corporation |
Novel compounds
|
|
JP2001517245A
(ja)
|
1997-05-29 |
2001-10-02 |
メルク エンド カンパニー インコーポレーテッド |
細胞接着阻害薬としてのビアリールアルカン酸類
|
|
EP1001764A4
(en)
|
1997-05-29 |
2005-08-24 |
Merck & Co Inc |
HETEROCYCLIC AMIDE COMPOUNDS AS INHIBITORS OF CELL ADHESION
|
|
WO1998053818A1
(en)
|
1997-05-29 |
1998-12-03 |
Merck & Co., Inc. |
Sulfonamides as cell adhesion inhibitors
|
|
AU7667498A
(en)
|
1997-05-30 |
1998-12-30 |
Celltech Therapeutics Limited |
Anti-inflammatory tyrosine derivatives
|
|
US6191269B1
(en)
|
1997-05-30 |
2001-02-20 |
The Regents Of The University Of California |
Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
|
|
AU8163398A
(en)
|
1997-06-23 |
1999-01-04 |
Pharmacia & Upjohn Company |
Inhibitors of alpha4beta1mediated cell adhesion
|
|
JP2001512137A
(ja)
|
1997-07-31 |
2001-08-21 |
エラン・ファーマシューティカルズ・インコーポレーテッド |
Ｖｌａ−４により媒介される白血球の付着を阻害するジペプチド化合物
|
|
KR20010022411A
(ko)
|
1997-07-31 |
2001-03-15 |
진 엠. 듀발 |
Ｖｌａ-4에 의해 매개되는 백혈구 부착을 억제하는 치환된페닐알라닌계의 화합물
|
|
WO1999006436A1
(en)
|
1997-07-31 |
1999-02-11 |
Elan Pharmaceuticals, Inc. |
Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
IL133639A0
(en)
|
1997-07-31 |
2001-04-30 |
Elan Pharm Inc |
Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
BR9812118A
(pt)
|
1997-07-31 |
2000-07-18 |
Elan Pharm Inc |
Compostos do tipo 4-amino-fenilalanina que inibem adesão de leucócito mediada por vla-4
|
|
PL338457A1
(en)
|
1997-07-31 |
2000-11-06 |
Elan Pharm Inc |
Sulphonylated dipeptidic compounds capable to inhibit adhesion of leucocytes through the mediation of vla-4
|
|
AU8678698A
(en)
|
1997-07-31 |
1999-02-22 |
American Home Products Corporation |
Compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
AR016133A1
(es)
|
1997-07-31 |
2001-06-20 |
Wyeth Corp |
Compuesto de carbamiloxi que inhiben la adhesion de leucocitos mediada por vla-4, compuestos que son prodrogas de dichos compuestos, composicionfarmaceutica, metodo para fijar vla-4 a una muestra biologica, metodo para el tratamiento de una condicion inflamatoria
|
|
CN1276785A
(zh)
|
1997-08-22 |
2000-12-13 |
霍夫曼-拉罗奇有限公司 |
N－烷酰基苯丙氨酸衍生物
|
|
US6455550B1
(en)
|
1997-08-22 |
2002-09-24 |
Hoffmann-La Roche Inc. |
N-alkanoylphenylalanine derivatives
|
|
US6229011B1
(en)
|
1997-08-22 |
2001-05-08 |
Hoffman-La Roche Inc. |
N-aroylphenylalanine derivative VCAM-1 inhibitors
|
|
EP1005445B1
(en)
|
1997-08-22 |
2004-05-26 |
F. Hoffmann-La Roche Ag |
N-alkanoylphenylalanine derivatives
|
|
DE19741235A1
(de)
|
1997-09-18 |
1999-03-25 |
Hoechst Marion Roussel De Gmbh |
Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
WO1999020272A1
(en)
|
1997-10-21 |
1999-04-29 |
Merck & Co., Inc. |
Azapeptide acids as cell adhesion inhibitors
|
|
PT1027328E
(pt)
|
1997-10-31 |
2006-11-30 |
Aventis Pharma Ltd |
Anilidas substituídas
|
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
|
AU1415099A
(en)
|
1997-11-18 |
1999-06-07 |
Merck & Co., Inc. |
4-substituted-4-piperidine carboxamide derivatives
|
|
DE19751251A1
(de)
|
1997-11-19 |
1999-05-20 |
Hoechst Marion Roussel De Gmbh |
Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
|
|
AU1411499A
(en)
|
1997-11-20 |
1999-06-15 |
Merck & Co., Inc. |
Para-aminomethylaryl carboxamide derivatives
|
|
WO1999026922A1
(en)
|
1997-11-21 |
1999-06-03 |
Merck & Co., Inc. |
Substituted pyrrole derivatives as cell adhesion inhibitors
|
|
AU750175B2
(en)
|
1997-11-24 |
2002-07-11 |
Merck & Co., Inc. |
Cyclic amino acid derivatives as cell adhesion inhibitors
|
|
AU751950B2
(en)
|
1997-11-24 |
2002-09-05 |
Merck & Co., Inc. |
Substituted beta-alanine derivatives as cell adhesion inhibitors
|
|
US6197794B1
(en)
|
1998-01-08 |
2001-03-06 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
MY153569A
(en)
|
1998-01-20 |
2015-02-27 |
Mitsubishi Tanabe Pharma Corp |
Inhibitors of ?4 mediated cell adhesion
|
|
KR20010034317A
(ko)
|
1998-01-23 |
2001-04-25 |
한스 루돌프 하우스 |
Ｖｌａ-4 길항제
|
|
US6329372B1
(en)
|
1998-01-27 |
2001-12-11 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
US6171809B1
(en)
|
1998-01-29 |
2001-01-09 |
Packard Instrument Company |
Method and compositions for detecting luciferase biological samples
|
|
DE69919334T2
(de)
|
1998-02-26 |
2005-08-04 |
Celltech Therapeutics Ltd., Slough |
Phenylalaninderivate als inhibitoren von alpha4 integrinen
|
|
DK1069185T3
(da)
|
1998-04-03 |
2011-06-27 |
Chugai Pharmaceutical Co Ltd |
Humaniseret antistof mod human vævsfaktor (TF) og fremgangsmåde til at konstruere humaniseret antistof
|
|
GB9811159D0
(en)
|
1998-05-22 |
1998-07-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
NZ509199A
(en)
|
1998-05-28 |
2003-10-31 |
Biogen Inc |
A VLA-4 inhibitor: oMePUPA-V
|
|
GB9812088D0
(en)
|
1998-06-05 |
1998-08-05 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6685617B1
(en)
|
1998-06-23 |
2004-02-03 |
Pharmacia & Upjohn Company |
Inhibitors of α4β1 mediated cell adhesion
|
|
US6355678B1
(en)
*
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
|
GB9821061D0
(en)
|
1998-09-28 |
1998-11-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
HU229888B1
(en)
|
1998-10-16 |
2014-11-28 |
Biogen Idec Ma Inc Cambridge |
Polymer conjugates of interferon betha-1a and uses
|
|
JP3180906B2
(ja)
|
1998-11-12 |
2001-07-03 |
日本電気株式会社 |
磁気抵抗効果型複合ヘッドの製造方法
|
|
KR100649819B1
(ko)
|
1999-02-18 |
2007-02-28 |
에프. 호프만-라 로슈 아게 |
티오아미드 유도체
|
|
US6265572B1
(en)
|
1999-04-20 |
2001-07-24 |
Hoffmann-La Roche Inc. |
Pyrrolidincarbonylamino cyclic disulfide anti-inflammatory agents
|
|
US6756378B2
(en)
|
1999-06-30 |
2004-06-29 |
Pharmacopeia Drug Discovery, Inc. |
VLA-4 inhibitor compounds
|
|
US7067313B1
(en)
|
1999-07-14 |
2006-06-27 |
D. Collen Research Foundation |
Ligands for use in therapeutic compositions for the treatment of hemostasis disorders
|
|
US6365619B1
(en)
|
1999-07-22 |
2002-04-02 |
Novartis Ag |
Treatment of arteriosclerosis
|
|
CZ2002518A3
(cs)
|
1999-08-13 |
2002-05-15 |
Biogen, Inc. |
Inhibitory buněčné adheze a farmaceutické prostředky, které je obsahují
|
|
US6531122B1
(en)
|
1999-08-27 |
2003-03-11 |
Maxygen Aps |
Interferon-β variants and conjugates
|
|
DK1083224T3
(da)
|
1999-09-02 |
2007-04-10 |
Leadd Bv |
Apoptin-associerende protein
|
|
EP1094110A1
(en)
|
1999-10-21 |
2001-04-25 |
Leadd B.V. |
Apoptosis inducing proteinaceous substance
|
|
DE60033684T2
(de)
|
1999-11-18 |
2007-12-06 |
Ajinomoto Co., Inc. |
Phenylalaninderivate
|
|
US6380387B1
(en)
|
1999-12-06 |
2002-04-30 |
Hoffmann-La Roche Inc. |
4-Pyrimidinyl-n-acyl-l phenylalanines
|
|
US6388084B1
(en)
|
1999-12-06 |
2002-05-14 |
Hoffmann-La Roche Inc. |
4-pyridinyl-n-acyl-l-phenylalanines
|
|
CZ20022352A3
(cs)
|
1999-12-06 |
2003-05-14 |
F. Hoffmann-La Roche Ag |
4-pyridinyl-N-acyl-L-fenylalaniny
|
|
DE19962936A1
(de)
|
1999-12-24 |
2001-06-28 |
Bayer Ag |
Neue beta-Aminosäureverbindungen als Integrinantagonisten
|
|
YU41202A
(sh)
|
1999-12-28 |
2005-03-15 |
Pfizer Products Inc. |
Ne-peptidni inhibitori vezivanja za ćeliju zavisnog od vla-4 korisni pri tretiranju inflamatornih, autoimunih i respiratornih bolesti
|
|
EP1243577A4
(en)
|
1999-12-28 |
2005-06-08 |
Ajinomoto Kk |
NEW PHENYLALANINE DERIVATIVES
|
|
US7446174B2
(en)
|
2001-03-02 |
2008-11-04 |
Xencor, Inc. |
Protein based TNF-α variants for the treatment of TNF-α related disorders
|
|
EP1270547A4
(en)
|
2000-03-23 |
2005-07-13 |
Ajinomoto Kk |
NEW PHENYL ALANIDE DERIVATIVES
|
|
DE60118362T2
(de)
|
2000-05-19 |
2007-05-24 |
The Center for Blood Research, Inc., Boston |
VERFAHREN ZUR BEHANDLUNG VON HÄMOSTATISCHEN STÖRUNGEN DURCH LöSLICHES P-SELECTIN
|
|
GB0027328D0
(en)
*
|
2000-06-23 |
2000-12-27 |
Aventis Pharma Inc |
Bioengineered vehicles for targeted nucleic acid delivery
|
|
US20040247565A1
(en)
|
2000-07-19 |
2004-12-09 |
Chih-Ping Liu |
Method of treatment using interferon-tau
|
|
US7015216B2
(en)
|
2000-07-21 |
2006-03-21 |
Elan Pharmaceuticals, Inc. |
Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors
|
|
WO2002008206A1
(en)
|
2000-07-21 |
2002-01-31 |
Elan Pharmaceuticals, Inc. |
3-amino-2-(4-aminocarbonyloxy)phenyl-propionic acid derivatives as alpha-4- integrin inhibitors
|
|
CA2420040C
(en)
|
2000-08-18 |
2009-02-03 |
Ajinomoto Co., Inc. |
New phenylalanine derivatives
|
|
CN1458922A
(zh)
|
2000-09-14 |
2003-11-26 |
东丽株式会社 |
尿素衍生物及以其作为有效成分的粘连分子阻断剂
|
|
WO2002024697A1
(en)
|
2000-09-25 |
2002-03-28 |
Toray Industries, Inc. |
Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
|
|
WO2002028830A1
(en)
|
2000-09-29 |
2002-04-11 |
Ajinomoto Co.,Inc. |
Novel phenylalanine derivatives
|
|
US6818216B2
(en)
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
|
CA2434666A1
(en)
|
2001-02-22 |
2002-09-06 |
Celltech R&D Limited |
Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
|
|
ES2180416B1
(es)
*
|
2001-03-12 |
2004-06-01 |
BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. |
Procedimiento para la preparacion de mezclas de reaccion estabilizadas, total o parcialmente desecadas, que comprenden, al menos, una enzima, mezclas de reaccion y kits que las contienen.
|
|
WO2003007889A2
(en)
|
2001-07-17 |
2003-01-30 |
Research Development Foundation |
Therapeutic agents comprising pro-apoptotic proteins
|
|
WO2003010135A1
(en)
|
2001-07-26 |
2003-02-06 |
Ajinomoto Co., Inc. |
Novel phenylpropionic acid derivatives
|
|
US6900292B2
(en)
*
|
2001-08-17 |
2005-05-31 |
Lee-Hwei K. Sun |
Fc fusion proteins of human erythropoietin with increased biological activities
|
|
WO2003053926A1
(en)
|
2001-12-13 |
2003-07-03 |
Ajinomoto Co.,Inc. |
Novel phenylalanine derivative
|
|
KR101271635B1
(ko)
*
|
2001-12-21 |
2013-06-12 |
휴먼 게놈 사이언시즈, 인코포레이티드 |
알부민 융합 단백질
|
|
AU2002364586A1
(en)
*
|
2001-12-21 |
2003-07-30 |
Delta Biotechnology Limited |
Albumin fusion proteins
|
|
US20030166559A1
(en)
|
2002-01-04 |
2003-09-04 |
Desjarlais John R. |
Dominant negative proteins and methods thereof
|
|
WO2003080611A1
(en)
|
2002-03-22 |
2003-10-02 |
Toray Industries, Inc. |
Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
|
|
US7332585B2
(en)
*
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
US7332580B2
(en)
*
|
2002-04-05 |
2008-02-19 |
The Regents Of The University Of California |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
GB0216571D0
(en)
|
2002-07-17 |
2002-08-28 |
Celltech R&D Ltd |
Chemical compounds
|
|
GB0216568D0
(en)
|
2002-07-17 |
2002-08-28 |
Celltech R&D Ltd |
Chemical compounds
|
|
US7314613B2
(en)
|
2002-11-18 |
2008-01-01 |
Maxygen, Inc. |
Interferon-alpha polypeptides and conjugates
|
|
US7413874B2
(en)
|
2002-12-09 |
2008-08-19 |
University Of Miami |
Nucleic acid encoding fluorescent proteins from aquatic species
|
|
US20040115204A1
(en)
|
2002-12-11 |
2004-06-17 |
Fanger Gary R. |
Antibodies to treat cancer
|
|
WO2004078112A2
(en)
|
2003-03-07 |
2004-09-16 |
Asahi Kasei Pharma Corporation |
Apoptosis inducing gene
|
|
US7446125B2
(en)
|
2003-04-09 |
2008-11-04 |
Universidad Del Pais Vasco |
Derivatives of nitroproline compounds, processes of manufacture and uses in the treatment of integrin mediated disorders
|
|
GB0308511D0
(en)
|
2003-04-14 |
2003-05-21 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
US7183092B2
(en)
|
2003-10-03 |
2007-02-27 |
Board Of Control Of Michigan Technological University |
Modified luciferase
|
|
US7638331B2
(en)
|
2004-01-02 |
2009-12-29 |
The Administration of the Tulane Rducation Fund |
Directed apoptosis in COX-2 overexpressing cancer cells through expression targeted gene delivery
|
|
PT1737891E
(pt)
|
2004-04-13 |
2013-04-16 |
Hoffmann La Roche |
Anticorpos anti p-selectina
|
|
BRPI0510716A
(pt)
|
2004-05-05 |
2007-11-20 |
Merrimack Pharmaceuticals Inc |
uso de um agente de ligação bi-especìfico, agente de ligação bi-especìfico, composição de um agente de ligação bi-especìfico, e, kit
|
|
TW200610754A
(en)
|
2004-06-14 |
2006-04-01 |
Daiichi Seiyaku Co |
Vla-4 inhibitor
|
|
US7196112B2
(en)
|
2004-07-16 |
2007-03-27 |
Biogen Idec Ma Inc. |
Cell adhesion inhibitors
|
|
MX2007000891A
(es)
|
2004-07-23 |
2007-04-18 |
Genentech Inc |
Cristalizacion de anticuerpos o fragmentos de ellos.
|
|
CA2599606A1
(en)
|
2005-02-23 |
2006-08-31 |
Merrimack Pharmaceuticals, Inc. |
Bispecific binding agents for modulating biological activity
|
|
EP1888633A4
(en)
|
2005-05-18 |
2010-01-27 |
Maxygen Inc |
UNFOLDED INTERFERON ALPHA POLYPEPTIDE
|
|
EP1909814B1
(en)
|
2005-07-26 |
2015-06-24 |
Georg-August-Universität Göttingen Stiftung öffentlichen Rechts (ohne Bereich Humanmedizin) |
Peptides for induction and enhancement of apoptosis in tumor cells
|
|
ES2399563T3
(es)
|
2005-11-04 |
2013-04-02 |
Evrogen, Jsc |
Proteínas verdes fluorescentes modificadas y método para la utilización de las mismas
|
|
US20070243163A1
(en)
|
2006-02-17 |
2007-10-18 |
Chih-Ping Liu |
Respiratory tract delivery of interferon-tau
|
|
WO2007146038A2
(en)
*
|
2006-06-07 |
2007-12-21 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
WO2008033413A2
(en)
*
|
2006-09-14 |
2008-03-20 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
MX2010011145A
(es)
|
2008-04-11 |
2011-04-11 |
Merrimack Pharmaceuticals Inc |
Enlazadores de la albumina de suero humana y conjugados de la misma.
|